February 9, 2026
Industry Insider
A conversation with Alcon's Julie Brewer
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-om-staging.hbrsd.com/media/4tbpmbe0/010926-omd-web-covers-staff.jpg
Ophthalmology Management
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-om-staging.hbrsd.com/media/yegf1tcf/cover_jan26_web_new.jpg
Retinal Physician
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-om-staging.hbrsd.com/media/th3js22v/0126-gp-cover-web.jpg
Glaucoma Physician
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-om-staging.hbrsd.com/media/0jsmmz3o/op_1025_cover_final.jpg
Ophthalmic Professional
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-om-staging.hbrsd.com/media/jdnlmuh3/1025-oasc-cover-final.jpg
The Ophthalmic ASC
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-om-staging.hbrsd.com/media/aqbjxwjw/pp-cover.jpg
Presbyopia Physician
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-om-staging.hbrsd.com/media/npjdtl1w/cp_november_cover.jpg
Corneal Physician
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://pv-om-staging.hbrsd.com/media/mvqdq2hc/nrp_cover_october_2024.jpg
New Retinal Physician
February 9, 2026
A conversation with Alcon's Julie Brewer
January 12, 2026
A Conversation With BostonSight CMO Dr. Daniel Brocks
November 24, 2025
Industry Insider
Advancing patient outcomes requires more than internal ingenuity—it demands active partnerships with those who live and breathe the challenges of vision care every day.
By Antonio Boccardi, Andrew Chang,
November 1, 2025
Industry Insider
CorneaGen marks milestones as adoption of CTAK for keratoconus accelerates.
July 1, 2025
Industry Insider
Atsena Therapeutics’ founder and chief scientific officer discusses her role as CSO, the latest developments with ATSN-101, trends in the ocular gene therapy space, and more.
June 1, 2025
Industry Insider
Harrow’s chief scientific officer provides an update on Vevye and discusses the Vevye Access for All initiative, Harrow’s partnership with Cencora, and more.
May 1, 2025
Industry Insider
Riad Sherif, MD, discusses positive data from Oculis' phase 2 ACUITY trial of OCS-05 in acute optic neuritis, the significance this neuroprotective treatment will have for patients, and more.
April 1, 2025
Mikhail Boukhny, MS, PhD, discusses Serenity and Serenity Toric Premium Monofocal IOLs, EyeXchange Solutions, and other developments at BVI.
March 1, 2025
Terry Kim, MD, discusses his roles as CMO and head of global medical safety at Alcon, why and how he moved in this direction with his career, the Unity Vitreoretinal Cataract and Unity Cataract Systems, and more.
November 1, 2024
Yehia Hashad, MD, discusses his role as chief medical officer and executive vice president of research and development.
October 1, 2024
Phil Ferrone, MD, chief medical retina advisor, discusses his role.
August 30, 2024
CoFi’s Sean Hanlon
August 1, 2024
LENZ Therapeutics’ Eef Schimmelpennink
July 1, 2024
June 1, 2024
Alimera’s Rick Eiswirth
May 1, 2024
Gentex Corp.'s Neil Boehm
April 1, 2024
Erin Henry of Iveric Bio, An Astellas Company
March 1, 2024
Topcon Healthcare’s Mary Durbin
January 1, 2024
BioTissue’s Scheffer C.G. Tseng, MD, PhD
December 1, 2023
Ace Vision Group’s Dr. Annmarie Hipsley
October 1, 2023
SIGHT SCIENCES’ DR. REAY H. BROWN
September 1, 2023
VIALASE’S SHAWN O’NEIL
By Shawn O’Neil
August 1, 2023
TRUKERA MEDICAL'S ADAM SZARONOS
July 1, 2023
OPTHEA’S MEGAN BALDWIN
By Megan Baldwin, PhD, MAICD
June 1, 2023
ORASIS PHARMACEUTICALS’ ELAD KEDAR
By Elad Kedar
May 1, 2023
SANTEN’S DR. PETER SALLSTIG
By Peter Sallstig, MD, MBA
April 1, 2023
OPTOS’ ROB KENNEDY
March 1, 2023
STAAR SURGICAL’S DR. SCOTT D. BARNES
February 1, 2023
OYSTER POINT PHARMA'S DR. MARIAN MACSAI
January 1, 2023
PHYSICIAN RECOMMENDED NUTRICEUTICALS' DR. ALICE T. EPITROPOULOS
December 1, 2022
JOHNSON & JOHNSON VISION’S RAJESH RAJPAL, MD
November 1, 2022
BRUDER HEALTHCARE'S DR. CYNTHIA MATOSSIAN
October 1, 2022
VISIOX PHARMA’S RYAN BLEEKS
September 1, 2022
EYEPOINT PHARMACEUTICALS' NANCY LURKER
August 1, 2022
THÉA PHARMA'S SUSAN BENTON
July 1, 2022
AURION BIOTECH’S GREG KUNST
June 1, 2022
OCUPHIRE PHARMA’S MINA SOOCH
May 1, 2022
DIAMATRIX LTD'S MATTHEW DYKES
April 1, 2022
LUMITHERA INC.'S CLARK E. TEDFORD, PHD
March 1, 2022
IMPRIMISRX’S JOHN SAHAREK
February 1, 2022
RVL PHARMACEUTICALS' RAYMOND DOUGLAS
January 1, 2022
BVI'S SHERVIN KORANGY
Guardion Health Sciences David Evans
Genentech’s Christopher Brittain
Verana Health’s Hylton Kalvaria
Ivantis' Dave Van Meter
Nextech’s Jason Handza, DO
GlobeChek’s William Mallon, MD
Ocular Therapeutix’s Antony Mattessich
Nova Eye Medical’s Joe Bankovich
Optopol USA’s Bob Padula
Leiters’ Robin Smith Hoke
Quidel Corporation’s Robert Bujarski
TearClear’s Robert J. Dempsey
ALPHAEON CREDIT’S TONY SEYMOUR